craft-sa-dev Home  

PMC:1584416 / 30121-31580 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T5706 0-8 JJ denotes Clinical
T5707 9-17 NN denotes evidence
T5709 18-20 IN denotes in
T5710 21-28 NN denotes support
T5711 29-31 IN denotes of
T5712 32-36 DT denotes this
T5713 37-47 NN denotes hypothesis
T5708 48-53 VBZ denotes comes
T5714 54-58 IN denotes from
T5715 59-60 DT denotes a
T5716 61-67 NN denotes number
T5717 68-70 IN denotes of
T5718 71-73 NN denotes XP
T5720 74-89 NN denotes complementation
T5721 90-95 NN denotes group
T5722 96-97 NN denotes D
T5719 98-106 NNS denotes patients
T5723 107-111 WDT denotes that
T5725 112-114 VBP denotes do
T5726 115-118 RB denotes not
T5724 119-122 VB denotes fit
T5727 123-129 IN denotes within
T5728 130-133 DT denotes the
T5729 134-143 NN denotes framework
T5730 144-146 IN denotes of
T5731 147-150 DT denotes the
T5733 151-158 JJ denotes current
T5734 159-170 JJ denotes monoallelic
T5732 171-179 NN denotes paradigm
T5735 180-182 IN denotes of
T5736 183-186 NN denotes XPD
T5737 187-196 NNS denotes disorders
T5738 197-198 -LRB- denotes (
T5739 198-204 NN denotes Figure
T5740 205-206 CD denotes 5
T5741 206-207 -RRB- denotes )
T5742 207-208 . denotes .
T5743 208-636 sentence denotes In contrast to two hemizygous XPDXPCS patients carrying the XPDG47R- or XPDR666W-encoding alleles who died of the disease before 2 y of age, two compound heterozygous XPDXPCS patients carrying the same XPDG47R- or XPDR666W-encoding alleles in addition to the presumed null XPDL461V+del716−730 both had considerably milder disease symptoms and survived more than ten times longer (A. Lehmann, personal communication) (Figure 5).
T5744 209-211 IN denotes In
T5746 212-220 NN denotes contrast
T5747 221-223 IN denotes to
T5748 224-227 CD denotes two
T5750 228-238 JJ denotes hemizygous
T5751 239-246 NN denotes XPDXPCS
T5749 247-255 NNS denotes patients
T5752 256-264 VBG denotes carrying
T5753 265-268 DT denotes the
T5755 269-276 NN denotes XPDG47R
T5757 276-277 HYPH denotes -
T5758 278-280 CC denotes or
T5759 281-289 NN denotes XPDR666W
T5760 289-290 HYPH denotes -
T5756 290-298 VBG denotes encoding
T5754 299-306 NNS denotes alleles
T5761 307-310 WP denotes who
T5762 311-315 VBD denotes died
T5763 316-318 IN denotes of
T5764 319-322 DT denotes the
T5765 323-330 NN denotes disease
T5766 331-337 IN denotes before
T5767 338-339 CD denotes 2
T5768 340-341 NNS denotes y
T5769 342-344 IN denotes of
T5770 345-348 NN denotes age
T5771 348-350 , denotes ,
T5772 350-353 CD denotes two
T5774 354-362 JJ denotes compound
T5775 363-375 JJ denotes heterozygous
T5776 376-383 NN denotes XPDXPCS
T5773 384-392 NNS denotes patients
T5777 393-401 VBG denotes carrying
T5778 402-405 DT denotes the
T5780 406-410 JJ denotes same
T5781 411-418 NN denotes XPDG47R
T5783 418-419 HYPH denotes -
T5784 420-422 CC denotes or
T5785 423-431 NN denotes XPDR666W
T5786 431-432 HYPH denotes -
T5782 432-440 VBG denotes encoding
T5779 441-448 NNS denotes alleles
T5787 449-451 IN denotes in
T5788 452-460 NN denotes addition
T5789 461-463 IN denotes to
T5790 464-467 DT denotes the
T5792 468-476 VBN denotes presumed
T5793 477-481 JJ denotes null
T5794 482-490 NN denotes XPDL461V
T5795 490-491 SYM denotes +
T5796 491-497 NN denotes del716
T5797 497-498 HYPH denotes −
T5791 498-501 NN denotes 730
T5798 502-506 DT denotes both
T5745 507-510 VBD denotes had
T5799 511-523 RB denotes considerably
T5800 524-530 JJR denotes milder
T5802 531-538 NN denotes disease
T5801 539-547 NNS denotes symptoms
T5803 548-551 CC denotes and
T5804 552-560 VBD denotes survived
T5805 561-565 JJR denotes more
T5807 566-570 IN denotes than
T5806 571-574 CD denotes ten
T5808 575-580 NNS denotes times
T5809 581-587 RBR denotes longer
T5810 588-589 -LRB- denotes (
T5811 589-591 NNP denotes A.
T5812 592-599 NNP denotes Lehmann
T5813 599-601 , denotes ,
T5814 601-609 JJ denotes personal
T5815 610-623 NN denotes communication
T5816 623-624 -RRB- denotes )
T5817 625-626 -LRB- denotes (
T5818 626-632 NN denotes Figure
T5819 633-634 CD denotes 5
T5820 634-635 -RRB- denotes )
T5821 635-636 . denotes .
T5822 636-751 sentence denotes Compound heterozygosity is also associated with the recently reported combination XP and TTD (XPTTD) syndrome [8].
T5823 637-645 NN denotes Compound
T5824 646-660 NN denotes heterozygosity
T5826 661-663 VBZ denotes is
T5827 664-668 RB denotes also
T5825 669-679 VBN denotes associated
T5828 680-684 IN denotes with
T5829 685-688 DT denotes the
T5831 689-697 RB denotes recently
T5832 698-706 VBN denotes reported
T5833 707-718 NN denotes combination
T5834 719-721 NN denotes XP
T5835 722-725 CC denotes and
T5836 726-729 NN denotes TTD
T5837 730-731 -LRB- denotes (
T5838 731-736 NN denotes XPTTD
T5839 736-737 -RRB- denotes )
T5830 738-746 NN denotes syndrome
T5840 747-748 -LRB- denotes [
T5841 748-749 CD denotes 8
T5842 749-750 -RRB- denotes ]
T5843 750-751 . denotes .
T5844 751-896 sentence denotes Similar to the XpdTTD/†XPCS and XpdTTD/†XP mice described here, both patients with XPTTD described so far had intermediate hair cysteine values.
T5845 752-759 JJ denotes Similar
T5847 760-762 IN denotes to
T5848 763-766 DT denotes the
T5850 767-773 NN denotes XpdTTD
T5852 773-774 HYPH denotes /
T5851 774-779 NN denotes †XPCS
T5853 780-783 CC denotes and
T5854 784-790 NN denotes XpdTTD
T5856 790-791 HYPH denotes /
T5855 791-794 NN denotes †XP
T5849 795-799 NNS denotes mice
T5857 800-809 VBN denotes described
T5858 810-814 RB denotes here
T5859 814-816 , denotes ,
T5860 816-820 DT denotes both
T5861 821-829 NNS denotes patients
T5862 830-834 IN denotes with
T5863 835-840 NN denotes XPTTD
T5864 841-850 VBN denotes described
T5865 851-853 RB denotes so
T5866 854-857 RB denotes far
T5846 858-861 VBD denotes had
T5867 862-874 JJ denotes intermediate
T5869 875-879 NN denotes hair
T5870 880-888 NN denotes cysteine
T5868 889-895 NNS denotes values
T5871 895-896 . denotes .
T5872 896-1038 sentence denotes Furthermore, XPTTD patient XP38BR carried a “causative” TTD mutation in one allele and a novel point mutation encoding XPDL485P in the other.
T5873 897-908 RB denotes Furthermore
T5875 908-910 , denotes ,
T5876 910-915 NN denotes XPTTD
T5878 916-923 NN denotes patient
T5877 924-930 NN denotes XP38BR
T5874 931-938 VBD denotes carried
T5879 939-940 DT denotes a
T5881 941-942 `` denotes “
T5882 942-951 JJ denotes causative
T5883 951-952 '' denotes ”
T5884 953-956 NN denotes TTD
T5880 957-965 NN denotes mutation
T5885 966-968 IN denotes in
T5886 969-972 CD denotes one
T5887 973-979 NN denotes allele
T5888 980-983 CC denotes and
T5889 984-985 DT denotes a
T5891 986-991 JJ denotes novel
T5892 992-997 NN denotes point
T5890 998-1006 NN denotes mutation
T5893 1007-1015 VBG denotes encoding
T5894 1016-1024 NN denotes XPDL485P
T5895 1025-1027 IN denotes in
T5896 1028-1031 DT denotes the
T5897 1032-1037 JJ denotes other
T5898 1037-1038 . denotes .
T5899 1038-1326 sentence denotes Although the XPDL485P-encoding allele fails to complement viability in the haploid S. pombe rad15 deletion strain and is thus interpretable as a null allele [8], we nonetheless suggest that the combined XPTTD phenotype in this patient involves phenotypic contributions from both alleles.
T5900 1039-1047 IN denotes Although
T5902 1048-1051 DT denotes the
T5904 1052-1060 NN denotes XPDL485P
T5906 1060-1061 HYPH denotes -
T5905 1061-1069 VBG denotes encoding
T5903 1070-1076 NN denotes allele
T5901 1077-1082 VBZ denotes fails
T5908 1083-1085 TO denotes to
T5909 1086-1096 VB denotes complement
T5910 1097-1106 NN denotes viability
T5911 1107-1109 IN denotes in
T5912 1110-1113 DT denotes the
T5914 1114-1121 JJ denotes haploid
T5915 1122-1124 FW denotes S.
T5916 1125-1130 FW denotes pombe
T5917 1131-1136 NN denotes rad15
T5918 1137-1145 NN denotes deletion
T5913 1146-1152 NN denotes strain
T5919 1153-1156 CC denotes and
T5920 1157-1159 VBZ denotes is
T5921 1160-1164 RB denotes thus
T5922 1165-1178 JJ denotes interpretable
T5923 1179-1181 IN denotes as
T5924 1182-1183 DT denotes a
T5926 1184-1188 JJ denotes null
T5925 1189-1195 NN denotes allele
T5927 1196-1197 -LRB- denotes [
T5928 1197-1198 CD denotes 8
T5929 1198-1199 -RRB- denotes ]
T5930 1199-1201 , denotes ,
T5931 1201-1203 PRP denotes we
T5932 1204-1215 RB denotes nonetheless
T5907 1216-1223 VBP denotes suggest
T5933 1224-1228 IN denotes that
T5935 1229-1232 DT denotes the
T5937 1233-1241 JJ denotes combined
T5938 1242-1247 NN denotes XPTTD
T5936 1248-1257 NN denotes phenotype
T5939 1258-1260 IN denotes in
T5940 1261-1265 DT denotes this
T5941 1266-1273 NN denotes patient
T5934 1274-1282 VBZ denotes involves
T5942 1283-1293 JJ denotes phenotypic
T5943 1294-1307 NNS denotes contributions
T5944 1308-1312 IN denotes from
T5945 1313-1317 DT denotes both
T5946 1318-1325 NNS denotes alleles
T5947 1325-1326 . denotes .
T5948 1326-1459 sentence denotes Taken together, these data suggest a shift to a biallelic paradigm for compound heterozygous patients in XP complementation group D.
T5949 1327-1332 VBN denotes Taken
T5951 1333-1341 RB denotes together
T5952 1341-1343 , denotes ,
T5953 1343-1348 DT denotes these
T5954 1349-1353 NNS denotes data
T5950 1354-1361 VBP denotes suggest
T5955 1362-1363 DT denotes a
T5956 1364-1369 NN denotes shift
T5957 1370-1372 IN denotes to
T5958 1373-1374 DT denotes a
T5960 1375-1384 JJ denotes biallelic
T5959 1385-1393 NN denotes paradigm
T5961 1394-1397 IN denotes for
T5962 1398-1406 NN denotes compound
T5964 1407-1419 JJ denotes heterozygous
T5963 1420-1428 NNS denotes patients
T5965 1429-1431 IN denotes in
T5966 1432-1434 NN denotes XP
T5968 1435-1450 NN denotes complementation
T5969 1451-1456 NN denotes group
T5967 1457-1458 NN denotes D
T5970 1458-1459 . denotes .
R3848 T5706 T5707 amod Clinical,evidence
R3849 T5707 T5708 nsubj evidence,comes
R3850 T5709 T5707 prep in,evidence
R3851 T5710 T5709 pobj support,in
R3852 T5711 T5710 prep of,support
R3853 T5712 T5713 det this,hypothesis
R3854 T5713 T5711 pobj hypothesis,of
R3855 T5714 T5708 prep from,comes
R3856 T5715 T5716 det a,number
R3857 T5716 T5714 pobj number,from
R3858 T5717 T5716 prep of,number
R3859 T5718 T5719 compound XP,patients
R3860 T5719 T5717 pobj patients,of
R3861 T5720 T5719 compound complementation,patients
R3862 T5721 T5722 compound group,D
R3863 T5722 T5719 compound D,patients
R3864 T5723 T5724 dep that,fit
R3865 T5724 T5719 relcl fit,patients
R3866 T5725 T5724 aux do,fit
R3867 T5726 T5724 neg not,fit
R3868 T5727 T5724 prep within,fit
R3869 T5728 T5729 det the,framework
R3870 T5729 T5727 pobj framework,within
R3871 T5730 T5729 prep of,framework
R3872 T5731 T5732 det the,paradigm
R3873 T5732 T5730 pobj paradigm,of
R3874 T5733 T5732 amod current,paradigm
R3875 T5734 T5732 amod monoallelic,paradigm
R3876 T5735 T5732 prep of,paradigm
R3877 T5736 T5737 compound XPD,disorders
R3878 T5737 T5735 pobj disorders,of
R3879 T5738 T5739 punct (,Figure
R3880 T5739 T5708 parataxis Figure,comes
R3881 T5740 T5739 nummod 5,Figure
R3882 T5741 T5739 punct ),Figure
R3883 T5742 T5708 punct .,comes
R3884 T5744 T5745 prep In,had
R3885 T5746 T5744 pobj contrast,In
R3886 T5747 T5746 prep to,contrast
R3887 T5748 T5749 nummod two,patients
R3888 T5749 T5747 pobj patients,to
R3889 T5750 T5749 amod hemizygous,patients
R3890 T5751 T5749 compound XPDXPCS,patients
R3891 T5752 T5749 acl carrying,patients
R3892 T5753 T5754 det the,alleles
R3893 T5754 T5752 dobj alleles,carrying
R3894 T5755 T5756 npadvmod XPDG47R,encoding
R3895 T5756 T5754 amod encoding,alleles
R3896 T5757 T5755 punct -,XPDG47R
R3897 T5758 T5755 cc or,XPDG47R
R3898 T5759 T5755 conj XPDR666W,XPDG47R
R3899 T5760 T5756 punct -,encoding
R3900 T5761 T5762 dep who,died
R3901 T5762 T5754 relcl died,alleles
R3902 T5763 T5762 prep of,died
R3903 T5764 T5765 det the,disease
R3904 T5765 T5763 pobj disease,of
R3905 T5766 T5762 prep before,died
R3906 T5767 T5768 nummod 2,y
R3907 T5768 T5766 pobj y,before
R3908 T5769 T5768 prep of,y
R3909 T5770 T5769 pobj age,of
R3910 T5771 T5745 punct ", ",had
R3911 T5772 T5773 nummod two,patients
R3912 T5773 T5745 nsubj patients,had
R3913 T5774 T5773 amod compound,patients
R3914 T5775 T5773 amod heterozygous,patients
R3915 T5776 T5773 compound XPDXPCS,patients
R3916 T5777 T5773 acl carrying,patients
R3917 T5778 T5779 det the,alleles
R3918 T5779 T5777 dobj alleles,carrying
R3919 T5780 T5779 amod same,alleles
R3920 T5781 T5782 npadvmod XPDG47R,encoding
R3921 T5782 T5779 amod encoding,alleles
R3922 T5783 T5781 punct -,XPDG47R
R3923 T5784 T5781 cc or,XPDG47R
R3924 T5785 T5781 conj XPDR666W,XPDG47R
R3925 T5786 T5782 punct -,encoding
R3926 T5787 T5779 prep in,alleles
R3927 T5788 T5787 pobj addition,in
R3928 T5789 T5788 prep to,addition
R3929 T5790 T5791 det the,730
R3930 T5791 T5789 pobj 730,to
R3931 T5792 T5793 advmod presumed,null
R3932 T5793 T5791 amod null,730
R3933 T5794 T5791 nmod XPDL461V,730
R3934 T5795 T5791 punct +,730
R3935 T5796 T5791 compound del716,730
R3936 T5797 T5791 punct −,730
R3937 T5798 T5773 appos both,patients
R3938 T5799 T5800 advmod considerably,milder
R3939 T5800 T5801 amod milder,symptoms
R3940 T5801 T5745 dobj symptoms,had
R3941 T5802 T5801 compound disease,symptoms
R3942 T5803 T5745 cc and,had
R3943 T5804 T5745 conj survived,had
R3944 T5805 T5806 amod more,ten
R3945 T5806 T5808 nummod ten,times
R3946 T5807 T5806 quantmod than,ten
R3947 T5808 T5809 npadvmod times,longer
R3948 T5809 T5804 advmod longer,survived
R3949 T5810 T5811 punct (,A.
R3950 T5811 T5804 meta A.,survived
R3951 T5812 T5811 nmod Lehmann,A.
R3952 T5813 T5811 punct ", ",A.
R3953 T5814 T5811 amod personal,A.
R3954 T5815 T5811 nmod communication,A.
R3955 T5816 T5811 punct ),A.
R3956 T5817 T5818 punct (,Figure
R3957 T5818 T5804 parataxis Figure,survived
R3958 T5819 T5818 nummod 5,Figure
R3959 T5820 T5818 punct ),Figure
R3960 T5821 T5745 punct .,had
R3961 T5823 T5824 compound Compound,heterozygosity
R3962 T5824 T5825 nsubjpass heterozygosity,associated
R3963 T5826 T5825 auxpass is,associated
R3964 T5827 T5825 advmod also,associated
R3965 T5828 T5825 prep with,associated
R3966 T5829 T5830 det the,syndrome
R3967 T5830 T5828 pobj syndrome,with
R3968 T5831 T5832 advmod recently,reported
R3969 T5832 T5830 amod reported,syndrome
R3970 T5833 T5830 nmod combination,syndrome
R3971 T5834 T5830 nmod XP,syndrome
R3972 T5835 T5834 cc and,XP
R3973 T5836 T5834 conj TTD,XP
R3974 T5837 T5838 punct (,XPTTD
R3975 T5838 T5836 parataxis XPTTD,TTD
R3976 T5839 T5838 punct ),XPTTD
R3977 T5840 T5841 punct [,8
R3978 T5841 T5825 parataxis 8,associated
R3979 T5842 T5841 punct ],8
R3980 T5843 T5825 punct .,associated
R3981 T5845 T5846 advcl Similar,had
R3982 T5847 T5845 prep to,Similar
R3983 T5848 T5849 det the,mice
R3984 T5849 T5847 pobj mice,to
R3985 T5850 T5851 nmod XpdTTD,†XPCS
R3986 T5851 T5849 nmod †XPCS,mice
R3987 T5852 T5851 punct /,†XPCS
R3988 T5853 T5851 cc and,†XPCS
R3989 T5854 T5855 compound XpdTTD,†XP
R3990 T5855 T5851 conj †XP,†XPCS
R3991 T5856 T5855 punct /,†XP
R3992 T5857 T5849 acl described,mice
R3993 T5858 T5857 advmod here,described
R3994 T5859 T5846 punct ", ",had
R3995 T5860 T5861 det both,patients
R3996 T5861 T5846 nsubj patients,had
R3997 T5862 T5861 prep with,patients
R3998 T5863 T5862 pobj XPTTD,with
R3999 T5864 T5861 acl described,patients
R4000 T5865 T5866 advmod so,far
R4001 T5866 T5864 advmod far,described
R4002 T5867 T5868 amod intermediate,values
R4003 T5868 T5846 dobj values,had
R4004 T5869 T5870 compound hair,cysteine
R4005 T5870 T5868 compound cysteine,values
R4006 T5871 T5846 punct .,had
R4007 T5873 T5874 advmod Furthermore,carried
R4008 T5875 T5874 punct ", ",carried
R4009 T5876 T5877 compound XPTTD,XP38BR
R4010 T5877 T5874 nsubj XP38BR,carried
R4011 T5878 T5877 compound patient,XP38BR
R4012 T5879 T5880 det a,mutation
R4013 T5880 T5874 dobj mutation,carried
R4014 T5881 T5880 punct “,mutation
R4015 T5882 T5880 amod causative,mutation
R4016 T5883 T5880 punct ”,mutation
R4017 T5884 T5880 compound TTD,mutation
R4018 T5885 T5874 prep in,carried
R4019 T5886 T5887 nummod one,allele
R4020 T5887 T5885 pobj allele,in
R4021 T5888 T5874 cc and,carried
R4022 T5889 T5890 det a,mutation
R4023 T5890 T5874 conj mutation,carried
R4024 T5891 T5890 amod novel,mutation
R4025 T5892 T5890 compound point,mutation
R4026 T5893 T5890 acl encoding,mutation
R4027 T5894 T5893 dobj XPDL485P,encoding
R4028 T5895 T5890 prep in,mutation
R4029 T5896 T5897 det the,other
R4030 T5897 T5895 pobj other,in
R4031 T5898 T5874 punct .,carried
R4032 T5900 T5901 mark Although,fails
R4033 T5901 T5907 advcl fails,suggest
R4034 T5902 T5903 det the,allele
R4035 T5903 T5901 nsubj allele,fails
R4036 T5904 T5905 npadvmod XPDL485P,encoding
R4037 T5905 T5903 amod encoding,allele
R4038 T5906 T5905 punct -,encoding
R4039 T5908 T5909 aux to,complement
R4040 T5909 T5901 xcomp complement,fails
R4041 T5910 T5909 dobj viability,complement
R4042 T5911 T5909 prep in,complement
R4043 T5912 T5913 det the,strain
R4044 T5913 T5911 pobj strain,in
R4045 T5914 T5913 amod haploid,strain
R4046 T5915 T5913 nmod S.,strain
R4047 T5916 T5913 nmod pombe,strain
R4048 T5917 T5913 compound rad15,strain
R4049 T5918 T5913 compound deletion,strain
R4050 T5919 T5901 cc and,fails
R4051 T5920 T5901 conj is,fails
R4052 T5921 T5920 advmod thus,is
R4053 T5922 T5920 acomp interpretable,is
R4054 T5923 T5922 prep as,interpretable
R4055 T5924 T5925 det a,allele
R4056 T5925 T5923 pobj allele,as
R4057 T5926 T5925 amod null,allele
R4058 T5927 T5928 punct [,8
R4059 T5928 T5920 parataxis 8,is
R4060 T5929 T5928 punct ],8
R4061 T5930 T5907 punct ", ",suggest
R4062 T5931 T5907 nsubj we,suggest
R4063 T5932 T5907 advmod nonetheless,suggest
R4064 T5933 T5934 mark that,involves
R4065 T5934 T5907 ccomp involves,suggest
R4066 T5935 T5936 det the,phenotype
R4067 T5936 T5934 nsubj phenotype,involves
R4068 T5937 T5936 amod combined,phenotype
R4069 T5938 T5936 compound XPTTD,phenotype
R4070 T5939 T5936 prep in,phenotype
R4071 T5940 T5941 det this,patient
R4072 T5941 T5939 pobj patient,in
R4073 T5942 T5943 amod phenotypic,contributions
R4074 T5943 T5934 dobj contributions,involves
R4075 T5944 T5943 prep from,contributions
R4076 T5945 T5946 det both,alleles
R4077 T5946 T5944 pobj alleles,from
R4078 T5947 T5907 punct .,suggest
R4079 T5949 T5950 advcl Taken,suggest
R4080 T5951 T5949 advmod together,Taken
R4081 T5952 T5950 punct ", ",suggest
R4082 T5953 T5954 det these,data
R4083 T5954 T5950 nsubj data,suggest
R4084 T5955 T5956 det a,shift
R4085 T5956 T5950 dobj shift,suggest
R4086 T5957 T5956 prep to,shift
R4087 T5958 T5959 det a,paradigm
R4088 T5959 T5957 pobj paradigm,to
R4089 T5960 T5959 amod biallelic,paradigm
R4090 T5961 T5959 prep for,paradigm
R4091 T5962 T5963 nmod compound,patients
R4092 T5963 T5961 pobj patients,for
R4093 T5964 T5963 amod heterozygous,patients
R4094 T5965 T5963 prep in,patients
R4095 T5966 T5967 compound XP,D
R4096 T5967 T5965 pobj D,in
R4097 T5968 T5967 compound complementation,D
R4098 T5969 T5967 compound group,D
R4099 T5970 T5950 punct .,suggest